TRENDING TOPICS
3055 articles found for "investing"
Broadcom's AI chip backlog hit $73 billion with Q1 FY2026 AI revenue guidance of $8.2 billion, while a multi-year OpenAI partnership valued at over $100 billion positions the chipmaker as Nvidia's most formidable rival.
Caterpillar shares reach an all-time high of $723.32 as AI data center power orders fuel a record $51 billion backlog and the company's Power & Energy segment becomes its fastest-growing business.
South Korea's ruling party has pledged to ratify its US trade agreement by end of February after President Trump threatened to raise tariffs from 15% to 25% on automobiles, pharmaceuticals, and other key exports.
Ubiquiti reports record Q2 FY2026 revenue of $814.9 million, up 36% year-over-year, with adjusted EPS of $3.88 crushing the $3.08 consensus estimate as enterprise networking demand surges.
Bitcoin plunges to $60,033 in early Friday trading, breaching the critical $60,000 support level for the first time since October 2024 as forced liquidations exceed $2.7 billion and institutional demand reverses.
Centene reports Q4 2025 earnings with analysts expecting a loss of $1.25 per share despite 18% revenue growth, as soaring medical costs and Medicaid redeterminations squeeze the nation's biggest government health plan manager.
Novo Nordisk shares plunge 17% after the Ozempic maker warns of a 5% to 13% sales decline in 2026, while rival Eli Lilly guides for 27% growth — marking a stunning divergence in the $150 billion obesity drug market.
U.S. defense spending has crossed the $1 trillion threshold for the first time as Congress approves an $839 billion base budget plus $150 billion in reconciliation funding, sending Lockheed, Northrop, and L3Harris to new highs.
Alphabet, Amazon, Meta, and Microsoft are collectively planning to spend roughly $650 billion on AI infrastructure in 2026, more than doubling last year's outlay and sending investors scrambling to recalculate returns.
Electrical equipment maker Forgent Power Solutions priced its IPO at $27 per share, raising $1.5 billion in one of 2026's largest public offerings as AI-driven data center construction creates unprecedented demand.
Eli Lilly's orforglipron, the first oral GLP-1 weight loss pill, awaits FDA approval by April with 'national priority' status as Novo Nordisk stumbles on declining sales forecasts.
Shell reported adjusted earnings of $3.26 billion for Q4 2025, missing analyst expectations as lower oil prices and rocky trading conditions weighed on results.